Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.

Saved in:
Bibliographic Details
Title: Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.
Authors: Wang X; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Shinjo K; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. kshinjo@med.nagoya-u.ac.jp., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Maruyama R; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Mii S; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Shiraki Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Nishimura T; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Murofushi Y; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Suzuki M; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kabasawa T; Department of Pathology, Yamagata University, Yamagata, Japan., Futakuchi M; Department of Pathology, Yamagata University, Yamagata, Japan., Kanai A; Life Science Data Research Center, Graduate School of Frontier Sciences, the University of Tokyo, Chiba, Japan., Suzuki Y; Life Science Data Research Center, Graduate School of Frontier Sciences, the University of Tokyo, Chiba, Japan., Enomoto A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Japan., Kondo Y; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.; Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.; Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan. ykondo@med.nagoya-u.ac.jp.
Source: British journal of cancer [Br J Cancer] 2026 Feb; Vol. 134 (4), pp. 577-588. Date of Electronic Publication: 2025 Dec 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-025-03299-5